Industry News
Related Searches:
Filter by:
1426 - 1440 of 2387 results
March 20, 2009
SGS has opened a new microbiology lab offering full cGMP-compliant testing in its Shanghai, China facility.
Read More »
March 20, 2009
Stiefel Laboratories, Inc. has enlisted the advisory arm of Blackstone Group for assistance with the sale of the company, according to a source.
Read More »
March 20, 2009
SAFC, a member of the Sigma-Aldrich Group, has announced its new Vendor Audit Services aimed at companies seeking enhanced traceability and quality confirmation for critical raw materials and key intermediates for their manufacturing processes.
Read More »
March 19, 2009
Werum Software & Systems is expanding its business footprint in the Asia-Pacific region with subsidiaries in Japan and Singapore.
Read More »
March 19, 2009
Schott's Pharmaceutical Packaging business plans to expand both its product line and production capacity in the U.S.
Read More »
March 18, 2009
Vetter will launch a new subsidiary, Vetter Pharma International, on April 1 . . .
Read More »
March 18, 2009
Cedarburg Pharmaceuticals has acquired InB: Hauser Pharmaceutical Services. The acquisition is intended to strengthen Cedarburg’s position in the rapidly growing CDMO market . . .
Read More »
March 16, 2009
Roche has signed an agreement to acquire Innovatis, a German-based provider of automated cell analysis solutions, for $19.4 million. Innovatis will become a fully-integrated part of Roche Applied Science, the company’s diagnostic division.
Read More »
March 16, 2009
Spectrum Pharmaceuticals has completed the transaction acquiring control of RIT Oncology, LLC, to commercialize Zevalin ([90Y]-ibritumomab tiuxetan) in the U.S.
Read More »
March 13, 2009
Covance is expanding its clinical pharmacology footprint in Europe with the acquisition of Swiss Pharma Contract, a 50-bed clinical research company based in Basel, Switzerland.
Read More »
March 12, 2009
Roche and Genentech signed a merger agreement under which Roche will acquire outstanding Genentech shares for approximately $46.8 billion in cash.
Read More »
March 12, 2009
Gilead Sciences has entered into a definitive agreement to acquire CV Therapeutics for approximately $1.4 billion in cash through a tender offer and second-step merger.
Read More »
March 12, 2009
DSM Biomedical has obtained an exclusive worldwide license to a drug and biologics delivery system developed by MediVas LLC.
Read More »
March 11, 2009
JLL Patheon Holdings, LLC, an affiliate of JLL Partners, has offered $2.00 in cash per Restricted Voting Share for all outstanding shares of Patheon that it does not already own.
Read More »
March 11, 2009
Prasco Laboratories has entered into a marketing and distribution agreement with GlaxoSmithKline for generic Flonase Nasal Spray.
Read More »
1426 - 1440 of 2387 results
